Endocannabinoid System & Cannabis-Induced Psychosis Research
Cannabis-induced psychosis schizophrenia risk is a critical concern for clinicians. A significant portion of patients with cannabis-induced psychosis later develop schizophrenia spectrum or bipolar disorder. Early identification and structured follow-up…
Cannabinoid Clinical Trials: Digital Smoking Cessation for HIV
This pilot trial evaluates digital therapeutics smoking cessation HIV interventions tailored for people living with HIV. The study shows strong feasibility and acceptability of app-based cessation tools in this population. Digital therapeutics offer a…
Cannabidiol for Lennox-Gastaut: Clinical Trial Evidence and Insights
Clinically meaningful cannabidiol reduction offers new hope for Lennox-Gastaut syndrome patients by improving drop seizure outcomes. Recent clinical trials demonstrate that even reductions below 50% can be impactful. Caregiver reports support…
Endocannabinoid System Research: Cannabis for Endometriosis
Many people with endometriosis use cannabis for symptom relief, but clinical evidence is limited. This medicinal cannabis endometriosis trial evaluated safety and feasibility of inhaled THC and oral CBD oil. The study highlights challenges in conducting…
Cannabinoid Clinical Trials: CBD and WADA Drug Testing
2026 cannabis clinical trials reveal that broad-spectrum CBD supplements can lead to detectable WADA-prohibited cannabinoids in urine. Exercise amplifies these concentrations, increasing doping risk. Athletes should be cautious with CBD products to avoid…
Cannabinoid Clinical Trials: CBD, Psychosis & Brain Function
This study investigates CBD hippocampal glutamate modulation in individuals at clinical high risk for psychosis. Findings reveal CBD influences brain activity during verbal memory tasks. These results highlight CBD's potential neurochemical effects…
Endocannabinoid System Research: Cannabis Use in Pregnancy
Maternal cannabis use in pregnancy is linked to a modestly elevated risk of autism spectrum disorder and ADHD in children. This association is supported by pooled data from multiple observational studies. Current evidence advises caution due to potential…
Cannabis Derivatives for Autism: Clinical Evidence & Research
Several randomized clinical trials have examined cannabis derivatives autism spectrum disorder symptoms. Findings suggest potential benefits for behavioral challenges and social functioning. The evidence base remains limited, so no definitive clinical…
Endocannabinoid System & Teen Anxiety: Clinical Evidence
Internalising symptoms adolescent cannabis use is linked to increased risk of initiation and escalation among teens. This clinical evidence highlights the importance of screening for anxiety and depression in adolescents. Understanding these risks can…
Understanding the Risk of Psychiatric Disorders from Adolescent Cannabis Use
Adolescent cannabis psychiatric disorders risk includes increased chances of psychotic, bipolar, depressive, and anxiety disorders. This risk is supported by large population-level clinical data. Understanding this risk helps guide adolescent mental…